Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$348 Mln
Revenue (TTM)
$37 Mln
Net Profit (TTM)
$0 Mln
ROE
0.2 %
ROCE
-- %
P/E Ratio
5
P/B Ratio
0.7
Industry P/E
44.78
EV/EBITDA
99.7
Div. Yield
0 %
Debt to Equity
0.2
Book Value
$--
EPS
$2.7
Face value
--
Shares outstanding
15,142,195
CFO
$75.04 Mln
EBITDA
$77.68 Mln
Net Profit
$69.16 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Semler Scientific Inc (SMLR)
| 33.0 | 13.4 | -14.0 | -68.6 | -18.3 | -26.1 | 24.8 |
|
BSE Sensex*
| -13.4 | -9.8 | -13.9 | -3.6 | 7.5 | 7.9 | 11.2 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Semler Scientific Inc (SMLR)
| -71.7 | 21.7 | 34.2 | -64.0 | -2.5 | 95.8 | 39.5 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Semler Scientific, Inc. provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables... healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. The company's products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, family practitioners, healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry, such as risk assessment groups and retailers. It offers its products through sales representatives and distributors. The company was incorporated in 2007 and is headquartered in Santa Clara, California. Read more
CFO, Principal Accounting Officer, Head of Corp. Communications & Bus. Strategy and Secretary
Ms. Renae Cormier
CFO, Principal Accounting Officer, Head of Corp. Communications & Bus. Strategy and Secretary
Ms. Renae Cormier
Headquarters
Santa Clara, CA
Website
Our rating system has guided millions of investors in the past 20 years.
The share price of Semler Scientific Inc (SMLR) is $20.35 (NASDAQ) as of 21-Jan-2026 09:30 EDT. Semler Scientific Inc (SMLR) has given a return of -18.33% in the last 3 years.
The P/E ratio of Semler Scientific Inc (SMLR) is 5.04 times as on 23-Jan-2026, a 89 discount to its peers’ median range of 44.78 times.
The P/B ratio of Semler Scientific Inc (SMLR) is 0.68 times as on 23-Jan-2026, a 77 discount to its peers’ median range of 2.95 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2024
|
11.31
|
2.00
|
|
2023
|
16.64
|
4.77
|
|
2022
|
18.24
|
4.69
|
|
2021
|
43.49
|
16.45
|
|
2020
|
44.15
|
20.76
|
The 52-week high and low of Semler Scientific Inc (SMLR) are Rs 355.43 and Rs 14.89 as of 05-Apr-2026.
Semler Scientific Inc (SMLR) has a market capitalisation of $ 348 Mln as on 23-Jan-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Semler Scientific Inc (SMLR), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
$0.01
(
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.